When will the FDA approve Intellia Therapeutics' lonvo-z?

Lonvoguran Ziclumeran (lonvo-z) for Hereditary AngioedemaScience and Technologyindependent outcomes

Markets

3 active

24h volume

contracts, all markets

Open interest

3,402

contracts, all markets

Series

Intellia Therapeutics drug approval date

Markets in this event

Sorted by 24h volume.

Market	Yes bid	Yes ask	Last	Δ	Spread	Vol 24h	OI	Vol total	Closes	Status
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?Before October 2027KXFDAAPPROVALDATENTLA-LONV-27OCT01	90¢	96¢	54¢	−35¢	6¢	2	668	1,066	in 12mo	active
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

U.S. Food and Drug Administration.https://www.fda.gov/news-events/fda-newsroom/press-announcements
FDAhttps://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024
Intellia Therapeuticshttps://www.intelliatx.com/

Show JSON (markets omitted)

event11